✦ LIBER ✦

PNP15: COST-UTILITY ANALYSIS OF THE TREATMENT OF RELAPSING-REMITTING MULTIPLE SCLEROSIS WITH GLATIRAMER ACETATE OR INTERFERON BETA IN SPAIN

✍ Scribed by C Rubio-Terrés; F Medina; I Aristegui; G Izquierdo

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cost analysis of glatiramer acetate vs.

✍ Rainel Sanchez-de la Rosa, Eliazar Sabater, Miguel A Casado 📂 Article 📅 2013 🏛 Springer-Verlag 🌐 English ⚖ 206 KB

PND30 Cost Analysis of Glatiramer Acetat

✍ Sánchez-de la Rosa, R.; Sabater, E.; Casado, M.A. 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB

Efficacy, safety, and cost-effectiveness

✍ Boster, A.; Bartoszek, M. P.; O'Connell, C.; Pitt, D.; Racke, M. 📂 Article 📅 2011 🏛 SAGE Publications 🌐 English ⚖ 160 KB

Cost-Effectiveness of Glatiramer Acetate

✍ Darba, J.; Kaskens, L.; Sánchez-de la, R.osa R 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

Cost-effectiveness of glatiramer acetate

✍ Darbà, Josep; Kaskens, Lisette; Sánchez-de la Rosa, Rainel 📂 Article 📅 2014 🏛 Informa plc 🌐 English ⚖ 206 KB

PND28 Cost-Effectiveness Analysis of Int

✍ R. Sánchez-de la Rosa; E. Sabater; M.A. Casado 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 59 KB